Bausch Health Companies (BHC) Shares Outstanding (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Shares Outstanding (Entity) came in at $373.9 million in Q2 2026, up 1.12% year-over-year from $369.7 million in Q2 2025, and little changed quarter-over-quarter from $373.5 million in Q1 2026.
Analysis
Bausch Health Companies (BHC) Shares Outstanding (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Shares Outstanding (Entity) across 18 years of filings, most recently posting $373.9 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 1.12% year-over-year to $373.9 million; the TTM figure through Jun 2026 stood at $373.9 million (up 1.12% YoY), while the FY2025 annual figure was $370.5 million, up 0.73% from the prior year.
- Shares Outstanding (Entity) came in at $373.9 million for Q2 2026 at Bausch Health Companies, roughly flat from $373.5 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $373.9 million in Q2 2026 to a low of $361.3 million in Q1 2022.
- Average Shares Outstanding (Entity) over 5 years is $366.7 million, with a median of $366.8 million recorded in 2024.
- Year-over-year, Shares Outstanding (Entity) grew 0.63% in 2023 and rose 1.12% in 2026.
- Over 5 years, Shares Outstanding (Entity) stood at $361.9 million in 2022, then increased by 0.92% to $365.2 million in 2023, then grew by 0.71% to $367.8 million in 2024, then advanced by 0.73% to $370.5 million in 2025, then gained by 0.91% to $373.9 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $373.9 million in Q2 2026, $373.5 million in Q1 2026, and $370.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 1.17 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 1.16 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 832.44 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 319.20 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 375.00 Mn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 289.73 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 21.16 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 43.64 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 34.55 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | 259.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 375.00 Mn |
| Mar 31, 2026 | 372.80 Mn |
| Dec 31, 2025 | 370.90 Mn |
| Sep 30, 2025 | 371.30 Mn |
| Jun 30, 2025 | 370.90 Mn |
| Mar 31, 2025 | 369.60 Mn |
| Dec 31, 2024 | 368.00 Mn |
| Sep 30, 2024 | 368.40 Mn |
| Jun 30, 2024 | 367.90 Mn |
| Mar 31, 2024 | 366.80 Mn |
| Dec 31, 2023 | 364.90 Mn |
| Sep 30, 2023 | 365.40 Mn |
| Jun 30, 2023 | 364.80 Mn |
| Mar 31, 2023 | 363.30 Mn |
| Dec 31, 2022 | 362.00 Mn |
| Sep 30, 2022 | 362.50 Mn |
| Jun 30, 2022 | 362.20 Mn |
| Mar 31, 2022 | 360.80 Mn |
| Dec 31, 2021 | 358.90 Mn |
| Sep 30, 2021 | 359.60 Mn |